These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 1355678

  • 41. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.
    González MV, Alvarez V, Pello MF, Menéndez MJ, Suárez C, Coto E.
    J Clin Pathol; 1998 Apr; 51(4):294-8. PubMed ID: 9659241
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia.
    Majumdar S, Mondal BC, Ghosh M, Dey S, Mukhopadhyay A, Chandra S, Dasgupta UB.
    Eur J Cancer Prev; 2008 Apr; 17(2):125-32. PubMed ID: 18287869
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
    Watanabe M.
    Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
    [Abstract] [Full Text] [Related]

  • 48. Debrisoquin oxidation genotype and susceptibility to lung cancer.
    Agúndez JA, Martínez C, Ladero JM, Ledesma MC, Ramos JM, Martín R, Rodriguez A, Jara C, Benítez J.
    Clin Pharmacol Ther; 1994 Jan; 55(1):10-4. PubMed ID: 8299311
    [Abstract] [Full Text] [Related]

  • 49. Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.
    Heim MH, Meyer UA.
    Methods Enzymol; 1991 Jan; 206():173-83. PubMed ID: 1686063
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Genetic polymorphisms of drug metabolism.
    Meyer UA.
    Fundam Clin Pharmacol; 1990 Jan; 4(6):595-615. PubMed ID: 1982880
    [Abstract] [Full Text] [Related]

  • 56. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF, Zhang ZD, Zhang SC, Zheng SH, Jia HY, Gu SX.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 20; 87(43):3064-8. PubMed ID: 18261353
    [Abstract] [Full Text] [Related]

  • 57. [Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].
    Fengler JD, Baumgarten R, Eike E, Eike O, Siegmund W, Franke G, Zschiesche M.
    Z Gastroenterol; 1993 Feb 20; 31 Suppl 2():81-2. PubMed ID: 7483725
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.